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Background: A scarcity of human resources for health has been identified as one of the primary constraints to the
scale-up of the provision of Anti-Retroviral Treatment (ART). In South Africa there is a particularly severe lack of
pharmacists. The study aims to compare two task-shifting approaches to the dispensing of ART: Indirectly
Supervised Pharmacist’s Assistants (ISPA) and Nurse-based pharmaceutical care models against the standard of care
which involves a pharmacist dispensing ART.
Methods: A cross-sectional mixed methods study design was used. Patient exit interviews, time and motion
studies, expert interviews and staff costs were used to conduct a costing from the societal perspective. Six facilities
were sampled in the Western Cape province of South Africa, and 230 patient interviews conducted.
Results: The ISPA model was found to be the least costly task-shifting pharmaceutical model. However, patients
preferred receiving medication from the nurse. This related to a fear of stigma and being identified by virtue of
receiving ART at the pharmacy.
Conclusions: While these models are not mutually exclusive, and a variety of pharmaceutical care models will be
necessary for scale up, it is useful to consider the impact of implementing these models on the provider, patient
access to treatment and difficulties in implementation.
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The scarcity of human resources for health (HRH) has
been identified as one of the primary constraints to the
provision of anti-retroviral treatment (ART) to all who
need it [1–3]. Pharmaceutical services experience similar
workload pressures and staff shortages as those that
plague other services involving HRH. While the World
Health Organization’s (WHO) guidelines recommend a
minimum country average of 1 pharmacist per 2300
people, many low- and middle-income countries (LMIC)
have averages far above that level. South Africa has 1
pharmacist per 4332 people [4]. In conjunction with
international migration, and a preference for urban over
rural posts, South Africa also experiences a strong pull
of pharmacists away from the public health service and
into the private sector, with approximately 24% of regis-
tered pharmacists employed in the public sector which* Correspondence: Nicola.Foster@uct.ac.za
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distribution, and reproduction in any mediumserves more than 80% of the population [5]. This has led
to a gap in the systems and processes associated with
the safe provision of chronic (and specifically ART) drug
treatment which is crucial as adherence is becoming of
greater concern [4].
The substitution of scarce highly skilled health work-
ers with purpose trained mid-level workers (termed
task-shifting) is a logical strategy to address the scarcity
of HRH [6]. The primary aim of task-shifting is to facili-
tate increased patient access to health services, through
enabling a rapid scale-up of much needed health care
interventions, and lower HRH training and salary costs
[7]. In addition to the cost and efficiency benefits, mid-
level workers have been found to be more likely to re-
main and work in rural areas and follow treatment
guidelines. While quality of care has been cited as a con-
cern by critics, studies suggest that the quality of care
provided by mid-level workers is at least comparable to
that of their more highly qualified colleagues [8–11]. A
randomized non-inferiority trial conducted in primaryCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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doctor- versus nurse-monitored ART care, found that
nurse-monitored care was comparable to doctor-
monitored ART care and, therefore, supported task-
shifting [11].
The shortage of pharmacists in the public health sec-
tor of SA has led to the use of pharmacists’ assistants
and nurses to support the expansion of the ART
programme and to ensure that patients receive medica-
tion. However, evidence of the costs and benefits of
these models is lacking. There is little consensus in the
literature on the appropriate methodology to use in
comparing HRH staff mix in a health system, although
Fulton et al. (2011) have suggested that cost-
effectiveness analyses would be useful in ensuring that
appropriate comparisons are made [7]. Thus far, the
focus of staff mix evaluations has been on the delegation
of tasks from doctors to physician assistants [9,12–18],
from doctors to nurses [11,19–24], and from nurses to
community health workers [25–30], with a paucity of
studies referring to pharmaceutical care staff [31]. This
study, therefore, aims to evaluate critically the indirectly
supervised pharmacists’ assistant (ISPA) and nurse-based
pharmaceutical care models against the standard of care
which involves a pharmacist dispensing ART, on the
basis of cost, waiting and travel time and patient
preference.
Methods
Study design and setting
A cross-sectional, mixed method study design was used.
Data were collected using patient exit interviews, time
and motion studies, and expert interviews. The study
was conducted in a peri-urban district of the Western
Cape province of SA.
Sampling
Within the district, health care facilities were grouped
based on the pharmaceutical care model they used, with
two facilities sampled per group. For each group an
equal number of respondents was sampled, and the
desired sample size per facility was proportional to the
number of patients on treatment at the facility. System-
atic sampling was used to select adult respondents on
ART to interview while waiting for medication.
Data collection
A questionnaire was developed, piloted and interviewer-
administered, to collect data regarding the direct and in-
direct costs incurred in accessing treatment as well as
the acceptability of the service provided. Direct costs
included the cost of transport, any facility fees incurred,
the cost of employing someone to take over tasks (such
as child minding), accommodation if sleeping over, andthe cost of food and telecommunication while waiting at
the facility. Indirect costs were estimated by asking
respondents about income lost from taking time to
come to the facility, as well as the cost of time spent
travelling to the facility. Patient waiting time was esti-
mated by attaching a printed form to each patient’s
folder, noting the time at which they entered the facility
and pharmacy or nurse dispensers were asked to note
the time at which respondents received their medicine.
Collecting medication was considered to be the last con-
tact point in the service chain. The difference in time
was aggregated per facility and added to the average
travel time to estimate the indirect cost per respondent
per visit.
Health service expenditure and staffing data were
obtained through facility observation and expert inter-
views with service managers. In order to determine the
time spent by nurses on dispensing-related activities, the
researcher observed practice and asked nurses to esti-
mate time spent dispensing if a total of 100% represents
one work day. The cost of HRH was estimated from De-
partment of Health (DOH) advertisements for posts and
discussed with service managers to ensure accuracy.
The potential cost of upgrading a medicine room to a
dispensary, as required by the Pharmacy Act for a phar-
macist’s assistant to work in, was determined from a case
study of a facility within the same district where the re-
search was conducted, and sourced from the non-
governmental organization (NGO) which paid for the
upgrade.
Respondent preferences were explored by asking
whether they would prefer collecting medication from a
local clinic or hospital, in addition to asking whether a
nurse or pharmacist/pharmacist’s assistant dispensing
was preferable. Respondents were also asked to explain
their preferences.
Data analysis
Statistical analysis of data was conducted using STATA
10W [32]. For examining health care costs, Microsoft
ExcelW was used. All costs are presented in 2009/2010
prices and estimated costs were converted to US dollars
at the average exchange rate of the US dollar to South
African rand for the 2010 financial year of US$1 =R7.80
[33].
The cost analysis was conducted from a societal per-
spective, and includes health service and patient costs.
Given that the study is comparative, costs that are com-
mon across pharmaceutical care models were excluded
[34]. For example, given that the cost of ARV drugs per
patient does not vary between models, these costs were
excluded [35]. The costs of staff employed by donors
were included, in line with the donor mandate that these
functions are to be taken over by the DOH in the future
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the literature [37–39], patients’ waiting and transport
time, which differed significantly between facilities and
could be seen as a measure of efficiency of service
provision, were taken into account and the opportunity
cost was calculated using the minimum hourly rate for a
domestic worker in South Africa, US$0.94 per hour [40].
While cost analysis assumes that outcomes are similar,
an element of outcome measurement was included by
considering the acceptability of the respective services.
The open-ended or discussion questions of the exit
interview responses were analyzed using domain analysis
during which topics were identified, assigned a code,
and domains and sub-categories explored. A list of codes
was generated and used to explore the common (and
different) perspectives of the respondents [41].
Preliminary results of the analysis were discussed with
service managers to confirm assumptions and validate
results.
Ethics
The research was approved by the University of Cape
Town Health Science Faculty Human Research Ethics
Committee as well as by the Western Cape Department
of Health. The study was conducted in adherence to the
Declaration of Helsinki of the 25th World Medical As-
sembly and all respondents participated on the basis of
written informed consent [42].
Results
Only 19 patients refused to be interviewed. Of the 230
patient exit interviews conducted, 6 were excluded from
the analysis as respondents were either not on ART yet
or were collecting medication for someone else.
Respondent characteristics
The characteristics of respondents are summarized in
Table 1.
The unequal gender distribution of people who access
ART in public health facilities has been well documentedTable 1 Profile of respondents





mean age± standard deviation 36.2 ± 9.2 years
Employment
unemployed 140 62.8%
employed full-time 41 18.4%
employed part-time 42 18.8%[43–45]. The age distribution of respondents, with a
mean age of 36 years, is in line with the national profile
of those on ART [46]. The unemployment rate is signifi-
cantly higher at 62.8% than the overall Western Cape
provincial estimate of 20.3% of the population [47]. This
can partly be attributed to the organization of the SA
health system whereby those employed are more likely
to use private health care paid for by medical insurance.
Facility characteristics
The study was conducted in a peri-urban district, which
includes some more rural facilities. Table 2 summarizes
some of the key aspects of the service provided by the
facilities sampled.
Pharm clinic 1 represents a relatively well resourced
health centre, and had one full-time Pharmacist (Pharm),
and a Pharmacist’s Assistant (PA) exclusively dispensing
ART, with two nurses using an estimated 60% of their
working day in dispensing- related activities. This
included taking prescriptions to the pharmacy to be
filled, collecting medication and counseling patients on
drug use. This arrangement came about after patients
expressed their discomfort at waiting at the general
pharmacy window to collect their medication. Pharm
clinic 1 had the greatest proportion of Full-Time Equiva-
lent (FTE) dispensing staff at 3.2 FTE compared to
Pharm clinic 2 with 1.98 FTE. However, the ratio of
patients on ART to FTE staff at Pharm clinic 1 was at
586:1 far greater than 419:1 at Pharm clinic 2.
The ISPA facilities had similar absolute staff FTEs (1.2
versus 1.8) and ratios of patients on ART to FTE at
378:1 and 345:1, respectively. Thus, patient load does
not explain the high average waiting time at ISPA clinic
1 of four hours and seventeen minutes (see Figure 1).
This facility was struggling under the lack of a fulltime
ART physician, which slowed down the renewal of pre-
scriptions and ultimately the dispensing process. ISPA
clinic 2 also had significant assistance in the dispensing
process by the nurse; this included the ordering of medi-
cation for patients, and ensuring that the prescription is
in order for patients only coming for repeat medication.
The nurse-driven group had the fewest FTE dispensers
as nurses often only provided a once or twice weekly
outreach service to the site. The time spent by the PA
and Supervisory Pharmacist (SPharm) at the central
pharmacy in preparing prescriptions in patient-ready
packs was also included in the analysis. Notably the ratio
of patients on ART to FTE dispenser was considerably
lower than in either of the other pharmaceutical care
models at 300:1 and 308:1, respectively. One can, there-
fore, argue that the number of patients per FTE dispen-
sers required is highest for the pharmacist supported
model, which may be due to the increased efficiency of
“learning through doing” as these ART services have
Table 2 Summary characteristics of ART service by facility
Group A: full-time pharmacist Group B: pharmacist assistant
under indirect supervision
Group C: nurse-driven
Pharm clinic 1 Pharm clinic 2 ISPA clinic 1 ISPA clinic 2 Nurse clinic 1 Nurse clinic 2
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patient-ready packs to








































1 Pharm 0.66 Pharm 0.2 SPharmb 0.2 SPharm 0.2 SPharm 0.2 SPharm
1 PA 0.66 PA 1 PA 1 PA 0.2 PA 0.2 PA
0.6 Nurse 0.66 PA 0.6 Nurse 0.36 Nurse 0.2 Nurse
0.6 Nurse 0.08 Nurse
Number of
patients on ART
1874 829 454 621 228 210
Ratio of FTE staff
to patients
enrolled in care




38 (12–52) months 28 (15–49)
months
10 (4–21) months 7 (4–15) months 11 (5–15) months 11 (6–23) months
aCommunity day centre (CDC): a facility which is not open 24 hours a day, 7 days a week, but at which a broad range of primary health care services are
provided. It also offers accident and emergency services but not midwifery or surgery under general anaesthesia. Also provides access to x-rays, full-time
pharmacist and full-time dentist (vd Merwe, personal communication); bSPharm= supervisory pharmacist who supervises a maximum of 5 pharmacists assistants.
ART, anti-retroviral treatment. FTE, full time equivalent; SD, standard deviation.
Figure 1 Respondent travel- and waiting-time.
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patients than the newer “outreach” nurse supported fa-
cilities. It is also conceivable that staff trained in dispens-
ing (i.e., pharmacists and pharmacist’s assistants) bring
greater productive efficiency to the dispensing process
and the service, therefore, takes longer to reach “satur-
ation point” where new dispensing staff members are
needed.
Staff costs
Given that the main difference between the pharmaceut-
ical care models relates to the cost of HRH, it was the
primary focus in the cost analysis from the provider per-
spective. The provider (or staff ) cost per patient visit
(summarized in Table 3) for the nurse-driven pharma-
ceutical care model was at US$10.16 almost double that
of the pharmacist- or ISPA- models (US$6.55 and US
$5.74). This can be attributed largely to the difference in
salaries between a pharmacist’s assistant and a nurse.
In the ART programme, nurses working on outreach
services are generally more experienced and compen-
sated at a higher salary level. It is, therefore, important
to consider the trade-off involved in shifting dispensing
related tasks from pharmacists to nurses given the scar-
city of nurses. One could argue that the nurse’s time
may be better spent performing clinical duties for which
s/he is trained.
As would be expected, the direct costs incurred by
patients accessing treatment, reflected the level of
decentralization of the service. Patients paid the most at
the pharmacist-led model facilities, where they spent al-
most four times more on transport than at the more
decentralized ISPA- and nurse-driven facilities.
The cost of transport has been found to be a signifi-
cant barrier to patient access to ART in other studies
[48,49]. Similarly, when asked about the affordability of
direct costs incurred in attending the clinic, 90% of theTable 3 Average cost per patient visit (n=244)
Group A:
full-time pharmacist
Pharm clinic 1 Pharm clini
Average provider cost
Staff costs US$6.08 US$7.01
Total cost to provider per patient visit US$6.08 US$7.01
Average patient costs
Direct costs US$6.20 US$3.35
Indirect costsa US$5.42 US$5.09
Total cost to patient per visit US$11.62 US$8.45
Total societal costs for ART care per visit US$17.70 US$15.46
Percentage of respondents who incurred
direct costs, and found it unaffordable (n)
90% (36) 70% (14)
aThe average opportunity costs to those unemployed were estimated from the min
Labor, 2010).respondents at pharmacist-led and 67% at nurse-driven
pharmaceutical care model facilities indicated that the
costs incurred are unaffordable. This is certainly not sur-
prising, given the high level of unemployment among
respondents.
The average travel time is slightly less than that
reported by other studies. Rosen et al. (2007) documen-
ted travel times (round trip) of between 83 and 158 min-
utes [50]. In this study, travel time was between 45 and
127 minutes per round trip (shown in Figure 1). How-
ever, it is interesting to note that respondents in Rosen’s
study were unlikely to walk to the facility while we found
that up to 97% of patients from the more decentralized
sites walked to the facility. This would also impact on
the transport (direct) costs reported.
From the perspective of efficiency in service delivery,
it is striking that the average waiting times are on aver-
age higher in the ISPA and nurse clinics (see Figure 1)
although these facilities have relatively lower numbers of
ART patients per FTE staff member (see Table 2).
The costs per patient visit are summarized by the
pharmaceutical care modelin Table 4. The annual cost
per patient was calculated by multiplying the cost to
provider and patient per visit with the average number
of visits per year reported in the patient exit interviews.
There was less of a difference in the societal cost than in
the provider cost between the ISPA and nurse pharma-
ceutical care models; this is because the high cost to the
provider in the nurse model is partially offset by the
relatively low cost to the patient due to the decentralized
nature of the service.
While the annual cost per patient for the pharmacist
model is lower than for the ISPA model, the average cost
per visit is higher. This relates to the difference in the
average number of patient visits per year. Patients who
are stable and adherent on treatment are given enough




c 2 ISPA clinic 1 ISPA clinic 2 Nurse clinic 1 Nurse clinic 2
US$5.09 US$6.38 US$11.19 US$9.13
US$5.09 US$6.38 US$11.19 US$9.13
US$1.59 US$1.65 US$1.14 US$3.00
US$7.47 US$4.15 US$3.60 US$4.84
US$9.06 US$5.81 U$4.74 US$7.84
US$14.16 US$12.19 US$15.93 US$16.97
77.78% (21) 68% (17) 64.29% (9) 70.97% (22)
imum daily rate for a domestic worker in South Africa (SA Department of
Table 4 Incremental cost of ART service use, compared between different levels of service
Level of service Average number
of patient
visits per year
Cost to provider Cost to patient Societal cost Average annual cost per
patient for baseline, incremental





















7.78 US$ 6.55 US$ 10.04 US$16.58 US$128.99
ISPA 10.74 -US$ 0.81 -US$ 2.60 -US$3.40 US$12.56
Nurse 9.78 US$ 3.61 -US$ 3.75 -US$0.13 US$31.89
















Data sources: Lizette Monteith, Keth'Impilo; Lindsay Wilson, PGWC HIV
directorate and Margaret von Zeil, City of Cape Town.
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that the pharmacist model at more centralized facilities
has been available for longer, their patients have been on
treatment longer (see Table 2) and are, therefore, more
likely to visit the clinic less often. This decreases the
burden of care on the clinic and more patients can be
seen using similar resources, while minimizing the cost
to the patient.
The cost of upgrading a medicine room to a dispensary
While the ISPA model is the cost saving option to the
provider, there is an infrastructure upgrade required
when moving from the nurse- to the ISPA-model. For
the nurse model there is no need for a pharmacy or dis-
pensary as medication is prepared for the patient at a
central dispensary and merely handed out by the nurse
in patient-ready packs. However, the ISPA model
requires a dispensary to be registered with the South Af-
rican Pharmacy Council. We present these costs separ-
ately and it is not included in the average cost
comparison, as these medicine rooms should arguably
be upgraded regardless of level of pharmaceutical care
provided given that it is used for medication storage. It
is however important to be aware of this potential add-
itional cost. A case study from the district studied was
selected and expenditure costs obtained to provide an
idea of the approximate costs of an upgrade (Table 5).
A total cost of US$11 479.88 was spent in the upgrad-
ing of the facility. The costs for the upgrade included en-
larging of the medicine room, the installation of
concrete beams in the room to improve security, instal-
lation of a security gate, shelving and the purchasing of
a vaccine refrigerator as well as a backup household
refrigerator.
Sensitivity analysis
A sensitivity analysis was conducted to test what the im-
pact on the results would be if one were to vary some of
the assumptions. While the baseline represents thecurrent practice at the facilities, another “best practice”
scenario was set up whereby the observed assistance of
nursing staff in the pharmacist and ISPA models was
disregarded and all patients visited the clinic every two
months. The ratio of the cost for the ISPA to nurse
models was similar for the baseline scenario (see Table 6).
A “worst case” scenario was also set up, which involved
nurses according to their estimates (at 90% of their pro-
ductive time) and assumed that patients attended the
clinic monthly. For scenario 2, the ISPA model was still
less costly than the nurse model.
Patient preferences
The results of the cost analysis suggest that while both
of the decentralized approaches, the ISPA- and nurse-
driven pharmaceutical care models, significantly de-
crease direct and indirect costs to patients when acces-
sing treatment, the ISPA model once implemented
would also be the least costly to the provider per patient
visit (see Table 4). However, only considering the costs
Table 6 Sensitivity analyses of provider costs
Scenario Models Assumptions Outcomes













One pharmacist and one pharmacists assistant 6 US$4.61 US$27.64
ISPA One supervisory pharmacist and one pharmacists
assistant
US$4.46 US$26.77
Nurse-driven One supervisory pharmacist and one nurse US$11.11 US$66.65
2 Full-time
pharmacist
One pharmacist, one pharmacist’s assistant and
maximum nurse time estimate
12 US$8.81 US$105.72
ISPA Supervisory pharmacist, pharmacist’s assistants and
maximum nurse time estimate
US$8.92 US$107.08
Nurse-driven Supervisory pharmacist, pharmacist’s assistants and
maximum nurse time estimate
US$18.80 US$225.62
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tions of the specific models of care.
During the patient exit interviews, respondents were
also questioned about whether they would prefer to re-
ceive their medication from the nurse or from the phar-
macy. The response was most surprising from facilities
where the ISPA model had already been implemented.
The majority of respondents from these facilities indicated
that they would prefer to receive their medication directly
from the nurses. Here are some of their responses:
“I have to walk past people to get the pharmacy and
they might recognise me. Also for the time saved”
(Respondent, Pharm clinic 2)
“The people ask us somany questions that are not pleasant.
I don’t find it easy to collect them [her medication] at the
pharmacy ‘coz it is like automatic disclosure of my
status to everyone” (Respondent, ISPA clinic 1)
Many of the responses reflected a spatial component to
the stigma of HIV, related to being identified when seen
by other community members collecting medication
(visually known as ART) from the pharmacy. At one of
the ISPA model facilities, the identification of people who
are HIV positive was exacerbated by the use of a different
colored folder for those who are not on ART.
The fear of stigma and the value of anonymity also
played a central role in patients’ choice of health facility.
As some explained:
“I feel safer here; the people do not know me here. [It]
would’ve been cheaper to go to [facility name] but [I]
still rather come here.” (Respondent, Pharm clinic 1)“There are too many people in [facility name] and a
lot of people there talk badly about HIV
people.”(Respondent, Pharm clinic 1)
“My child gets ARV’s from [facility name] but I don’t
like it there. There are a lot of people there. If you go
that side everyone knows you are positive. Here
[current facility] we are not separate.” (Respondent,
Nurse clinic 1)
While respondents preferred receiving their medication
directly from the nurse as opposed to the pharmacy as
they felt that their anonymity was protected, there was a
trade-off. A challenge of the nurse-driven pharmaceutical
care model revolved around the logistics of ordering
medication for each patient based on their latest prescrip-
tion in advance of their appointment, and that patients
sometimes arrived out of appointment dates, requesting
medication. In an attempt to ensure that patient care con-
tinues, nurses would then open the pre-packed medica-
tion and dispense medication to patients from that
source. This is how respondents described it:
“They give you “bietjie bietjie” [little, little] tablets with
other people’s names on. It confuses us.” (Respondent,
Nurse clinic 2)
“Last month I came and they gave me treatment for
another person. Even now they gave me treatment for
a week and it’s not in my name.” (Respondent, Nurse
clinic 2)
“I don’t like the fact that I would come on my date
and leave the clinic without getting my pills, I have to
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with it.” (Respondent, Nurse clinic 2)
At one of the facilities, there were also concerns that
medication ordered but not collected, was stored in a
drawer. This left the stock open to be stolen, and if not
stored under the correct conditions, it could comprom-
ise patient safety.
Discussion
Each of the pharmaceutical care models has a unique set
of benefits and challenges, as summarized in Table 7.
The full-time pharmacist model is presented as the
standard of care that would be the ideal at every facility
and that has been found to promote rational prescribing
and, therefore, been cost saving [51]. However, with the
shortage of pharmacists, and an expensive four year
training program, this approach would limit the scale-up
of ART service provision.
The benefits of the ISPA model are that PAs undergo
only a two year in-service training course supervised byTable 7 Comparison of Pharmaceutical Care models
Pharmaceutical
care provider
Full-time Pharmacist available Pharmacist’s A
indirect super
Overview Full-time pharmacist dispensing
medication from a prescription written






by a doctor. Re
One pharmacis
to fivePAs.
Requirements Service is available at larger facilities, for
example, at a community health centre.
Dispensing is conducted from a
pharmacy, operated under the personal
supervision of a responsible pharmacist,








that of a pharm
size.
Benefits Highly skilled and trained health
professional, experienced in working
under pressure and in a team.
More cost-effe
costs [10]






Problems Scarce Insufficient trai
management,
providers)
Would limit scale-up of ART service Does not have
promote ration
Expensive training Limited pharm
Higher salary level Lack of careera pharmacist. The PA dispenses directly to the patient
and is responsible for stock control. In terms of supervi-
sion, one pharmacist can supervise up to five PAs simul-
taneously. Some concerns are that a PA might not be
getting sufficient training, they have limited pharmacol-
ogy training and do not have the authority to promote
rational prescribing. Osman (2005) makes the point that
PAs also lack a career path.
The nurse model is very useful in that it provides an
option for the rapid scale-up of ART services, although
it also reaches the saturation point sooner due to the
difficulties of ordering medication for each patient ap-
pointment. Medication is not dispensed directly to
patients but only from patient-ready packs with the
help of standard operating procedures. While there is a
perception that waiting time will be reduced when
nurses dispense medication, it is more likely that con-
sultation times will be longer and waiting times will
increase.
Where there was a lack of doctors to renew prescrip-




an offsite pharmacist who
thly visits and provides
port. Dispenses directly to
legal prescription written
sponsible for stock control.
t is allowed to supervise up
This service is often provided in
conjunction with an outreach service from
a larger centre or in small satellite clinics.
Medication is pre-packed by a pharmacist
for each patient (patient-ready packs) and
delivered to the clinic from which the
nurse hands out the medication and
monitors the patients’ condition.
to be secure, organized,
ntrolled. Pharmaceuticals
ducts are ordered, stored
directly to clients by the PA
staff for treatment areas.
ign and layout is similar to
acy but with smaller floor
Storage of medication in a medicine room.
The medicine room is intended as a
secure, organized, temperature controlled
room with limited access, for the bulk
storage of pharmaceuticals, for refilling
trolleys or cupboards in treatment rooms.
No direct patient dispensing, only from
patient-ready packs or according to
standard operating procedures.
ctive in salary and training Increases access to ART for patient
t in stock management and
s outside of appointment
Patients have established rapport with
clinician
s to ART There is a perception of time saved if
clinician dispenses, though each
consultation will take longer.
ning (operational
dealing with the public/
Prescriber and dispenser is the same
person – potential for mistakes.
the authority/skill to
al prescribing.
Nurses might not be aware of drug
interactions between drug classes.
acology training Service is likely to reach saturation point
sooner.
path [52] Higher salary level than PAs
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pensing process. While nurse prescribing was not a
model evaluated in this study, it has been proposed and
might conceivably decrease waiting times. However, it
does raise concerns when the prescriber and dispenser is
the same person, as there is there is a lack of quality
control.
The generalizability of this single district evaluation
could be seen as a limiting factor given that the func-
tioning of a facility is dependent on many facility-
specific characteristics, such as the level of skilled staff,
skill mix, the infrastructure available and staff motiv-
ation [53]. However, the study does provide a framework
within which to evaluate other facilities and some
experiences will be common to many facilities. An add-
itional limiting factor to the study is the lack of the facil-
ity staff members’ opinions on issues such as the
importance of the different color folders and influence
on patients’ access to treatment. Further research to ex-
plore health professionals’ opinions is recommended.
Conclusions
In reality, these pharmaceutical care models are not mu-
tually exclusive options and a variety of systems will no
doubt be required to achieve scale-up. While the ISPA
model is the least costly to the provider and to the pa-
tient, the concerns of patients in terms of confidentiality
and the avoidance of stigma needs to be addressed as it
could negatively impact on patients’ health seeking be-
haviour. In contrast, the nurse-driven pharmaceutical
care model is useful in rapidly scaling-up pharmaceutical
care and indeed rolling-out ART service provision to
new sites as capital outlay and the recruitment of dis-
pensing personnel is not needed. It does however place a
burden on nurses, uses more costly staff and reports
suggest that pharmaceutical care may be compromised
with patients needing to return to the health facility out-
side of scheduled appointments to collect medication
due to them. Both of these pharmaceutical care models
have a place in service provision, but it is imperative to
address quality of care and confidentiality concerns of
patients.
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